9^th World Dermatology and Pediatric Dermatology Congress

Biography

Biography: Salah Al Rubaie

Abstract

Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases that affect both children and adults with a prevalence of 30% and 10%, respectively. Even though most of patients respond satisfactory to topical anti-inflammatory drugs, about 10% require one or more systemic treatments to achieve good control of their illness. The progressive knowledge in the immune-pathogenesis of AD has allowed research on new therapeutic targets with very promising results in the field of biological therapy. In my talk, I will review the different biological treatments with a focus on novel drugs, their mechanism of action, side effects and results from different clinical trials and studies.